Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy
-
- Rita De Santis
- Biotechnology Research and Development, Alfasigma SpA, Rome, Italy
収録刊行物
-
- mAbs
-
mAbs 12 (1), 2020-01-01
Informa UK Limited